The issue was priced 10 percent above the ten-day weighted average share price, equal to DKK 8,21 per share.
Jens Munch says:
“DecideAct is developing well. Right now, times are turbulent, but we will get through this eventually, and I have always seen DecideAct as a long-term investment with great potential.
Therefore, the crisis doesn’t change anything for me, and I am pleased to have the opportunity to inject this extra capital.”